glp 1 availability Indications for GLP-1/GIP RA Summary Sheet and Beyond! GLP-1 Pipeline Update: February 2026
Description
pharmacies based on individual prescriptions
12 Commonly, patients may experience gastrointestinal disturbances such as nausea, vomiting, diarrhea, and constipation
Ongoing monitoring: Monthly visits for the first three months, then every 8-12 weeks thereafter, with repeat labs at the three- and six-month marks to confirm the medication is working safely
Therefore, initial studies could be designed to explore whether and how GLP-1R agonists alter GABAergic and dopaminergic pathways in the brain
if not, it may suggest a direct effect of GLP1RA on the risk of mental illnesses
